| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GSK-1904529A | GDSC1000 | pan-cancer | AAC | 0.047 | 0.2 |
| mRNA | manumycin A | CTRPv2 | pan-cancer | AAC | 0.046 | 0.2 |
| mRNA | cyanoquinoline 11 | CTRPv2 | pan-cancer | AAC | 0.073 | 0.2 |
| mRNA | MI-1 | CTRPv2 | pan-cancer | AAC | 0.056 | 0.2 |
| mRNA | XMD13-2 | GDSC1000 | pan-cancer | AAC | -0.043 | 0.2 |
| mRNA | 1S,3R-RSL-3 | CTRPv2 | pan-cancer | AAC | -0.048 | 0.2 |
| mRNA | lapatinib | CTRPv2 | pan-cancer | AAC | 0.051 | 0.2 |
| mRNA | fingolimod | CTRPv2 | pan-cancer | AAC | -0.051 | 0.2 |
| mRNA | BIBR-1532 | CTRPv2 | pan-cancer | AAC | 0.052 | 0.2 |
| mRNA | STF-31 | CTRPv2 | pan-cancer | AAC | 0.05 | 0.2 |